Maryland To Receive $849,000 From Pharmaceutical Settlement

BALTIMORE — Attorney General Douglas F. Gansler announced Tuesday that Maryland has joined with 49 other states and the federal government in a $500 million settlement to resolve civil and criminal allegations that Ranbaxy, a generic pharmaceutical manufacturer based in Gurgaon, India, introduced adulterated drugs into interstate commerce.

As a result, false or fraudulent claims were submitted to Maryland's Medicaid program.

"Nothing can be more important than the health and safety of our citizens," said Gansler. "This record settlement is an important victory for Maryland consumers who have every right to expect that the medicine they purchase is of the highest possible quality and meets or exceeds all federal standards." 
More